ARCHIVES

Cancer Groups Propose Six Characteristics Of Next FDA Head.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

NCI-Approved Clinical Trials

June 30, 2006

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985

ASCO, AACR Hold Last Joint annual Meeting, Vow to Encourage Basic-Clinical Interaction

May 28, 1993

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008